These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15187247)

  • 1. Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study.
    Kary S; Fritz J; Scherer HU; Burmester GR
    Rheumatology (Oxford); 2004 Jul; 43(7):819-20. PubMed ID: 15187247
    [No Abstract]   [Full Text] [Related]  

  • 2. [New classification criteria for rheumatoid arthritis].
    Scirè CA; Caporali R
    Reumatismo; 2010; 62(3):159-62. PubMed ID: 21052562
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do you diagnose rheumatoid arthritis early?
    Quinn MA; Green MJ; Conaghan P; Emery P
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):49-66. PubMed ID: 11358414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for altering rheumatoid arthritis outcome.
    Quinn MA; Emery P
    Rheum Dis Clin North Am; 2005 Nov; 31(4):763-72. PubMed ID: 16287596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The Dutch College of General Practitioners' practice guideline on arthritis].
    Lems WF; Kerstens PJ
    Ned Tijdschr Geneeskd; 2009; 153():A1368. PubMed ID: 20051167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case against haste in the treatment of rheumatoid arthritis: comment on the editorial by Pincus et al.
    Epstein WV
    Arthritis Rheum; 2003 Feb; 48(2):573-5; author reply 576-9. PubMed ID: 12571870
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of rheumatoid arthritis: strategies for achieving optimal outcomes.
    Gibofsky A; Yazici Y
    Ann Rheum Dis; 2010 Jun; 69(6):941-2. PubMed ID: 20498219
    [No Abstract]   [Full Text] [Related]  

  • 10. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in early diagnosis of rheumatoid arthritis].
    Kondo H; Sakai M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():289-92. PubMed ID: 15799363
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it time to optimize anchor therapy for rheumatoid arthritis?
    Bijlsma JW
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv1-2. PubMed ID: 22685270
    [No Abstract]   [Full Text] [Related]  

  • 14. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH; Lems WF; Kerstens PJ; Voskuyl AE; Dijkmans BA; Boers M
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract]   [Full Text] [Related]  

  • 15. Get aggressive with early diagnosis, treatment of arthritis.
    Healthc Demand Dis Manag; 1999 May; 5(5):65-70. PubMed ID: 10538471
    [No Abstract]   [Full Text] [Related]  

  • 16. Escalated conventional therapy for rheumatoid arthritis patients.
    Smith MD
    Rheumatology (Oxford); 2004 Sep; 43(9):1199; author reply 1199-1200. PubMed ID: 15317963
    [No Abstract]   [Full Text] [Related]  

  • 17. Early rheumatoid arthritis.
    Machold KP; Nell V; Stamm T; Aletaha D; Smolen JS
    Curr Opin Rheumatol; 2006 May; 18(3):282-8. PubMed ID: 16582693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
    Wolfe F; Caplan L; Michaud K
    J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
    [No Abstract]   [Full Text] [Related]  

  • 19. [The usefulness of the latest diagnostic and therapeutic criteria ACR/EULAR in the treatment of rheumatoid arthritis].
    Pytel A; Wrzosek Z; Demczyszak I; Brzyski J
    Wiad Lek; 2012; 65(4):225-31. PubMed ID: 23654143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis.
    Gardiner PV; Bell AL; Taggart AJ; Wright G; Kee F; Smyth A; McKane R; Lee J; Rooney ME; Whitehead E
    Ann Rheum Dis; 2005 Mar; 64(3):506-7. PubMed ID: 15708909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.